Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves

Journal of Veterinary Pharmacology and Therapeutics
B RamalingamS Rampal

Abstract

The pharmacokinetic-pharmacodynamic (PK/PD) modeling of enrofloxacin data using mutant prevention concentration (MPC) of enrofloxacin was conducted in febrile buffalo calves to optimize dosage regimen and to prevent the emergence of antimicrobial resistance. The serum peak concentration (Cmax ), terminal half-life (t1/2 K10) , apparent volume of distribution (Vd(area) /F), and mean residence time (MRT) of enrofloxacin were 1.40 ± 0.27 μg/mL, 7.96 ± 0.86 h, 7.74 ± 1.26 L/kg, and 11.57 ± 1.01 h, respectively, following drug administration at dosage 12 mg/kg by intramuscular route. The minimum inhibitory concentration (MIC), minimum bactericidal concentration, and MPC of enrofloxacin against Pasteurella multocida were 0.055, 0.060, and 1.45 μg/mL, respectively. Modeling of ex vivo growth inhibition data to the sigmoid Emax equation provided AUC24 h /MIC values to produce effects of bacteriostatic (33 h), bactericidal (39 h), and bacterial eradication (41 h). The estimated daily dosage of enrofloxacin in febrile buffalo calves was 3.5 and 8.4 mg/kg against P. multocida/pathogens having MIC90 ≤0.125 and 0.30 μg/mL, respectively, based on the determined AUC24 h /MIC values by modeling PK/PD data. The lipopolysaccharide-induced fever ...Continue Reading

References

Mar 1, 1990·Journal of Veterinary Pharmacology and Therapeutics·Z L Zeng, K F Fung
Jun 1, 1986·The Journal of Antimicrobial Chemotherapy·U GanzingerE Schütze
Feb 1, 1985·Journal of Pharmaceutical Sciences·F C LamD G Perrier
Mar 1, 1982·Journal of Pharmaceutical Sciences·D Perrier, M Mayersohn
Oct 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·K K Chan, M Gibaldi
May 1, 1993·Antimicrobial Agents and Chemotherapy·A ForrestJ J Schentag
Aug 1, 1995·Journal of Veterinary Pharmacology and Therapeutics·M SprengH Drugeon
Oct 1, 1995·Journal of Veterinary Pharmacology and Therapeutics·L KaartinenS Pyörälä
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·J M BlondeauK Drlica
Apr 30, 2002·International Journal of Antimicrobial Agents·D Andes, W A Craig
Jan 21, 2003·Emerging Infectious Diseases·Charles W Stratton
Jan 23, 2003·The Journal of Pharmacology and Experimental Therapeutics·Lynn O PostMichael J Myers
May 3, 2003·Research in Veterinary Science·F Shojaee Aliabadi, P Lees
Nov 5, 2004·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·L Tollefson
Dec 17, 2004·Journal of Veterinary Pharmacology and Therapeutics·P L Toutain, P Lees
Mar 18, 2005·The Journal of Antimicrobial Chemotherapy·Johan W MoutonGeorge L Drusano
Jun 23, 2006·Biopharmaceutics & Drug Disposition·Anubha GuptaE Niclas Jonsson
Nov 4, 2006·The Journal of Infectious Diseases·Junchang CuiXilin Zhao
Nov 17, 2006·Research in Veterinary Science·D J DimitrovaB Pandova
Nov 23, 2006·Research in Veterinary Science·M Ismail, Y A El-Kattan
Aug 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara K Olofsson, Otto Cars
Jul 16, 2008·International Journal of Antimicrobial Agents·Francesco Scaglione, Luca Paraboni

❮ Previous
Next ❯

Citations

Nov 9, 2019·Tropical Animal Health and Production·Pritam K SidhuJohann F Coetzee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.